Raymond James & Associates’s Annexon ANNX Stock Holding History
Bought
Maintained
Sold
Other funds holding ANNX
EAM
BCLSI
RG
PAMS
AIM
Raymond James & Associates's ANNX Position: Q1 2022 in Review
Raymond James & Associates sold out of Annexon (ANNX) in Q1 2022, closing a stake of 22,048 shares — an estimated $253K sold.
Raymond James & Associates first reported a position in ANNX in Q3 2021 and held it in 2 quarters. The position peaked at $410K in Q3 2021. 101 funds tracked by Wall St. Rank hold ANNX as of Q1 2022.
- Raymond James & Associates reported no remaining Annexon position as of Q1 2022 after selling out during the quarter.
- Raymond James & Associates sold 22,048 Annexon shares in Q1 2022, an estimated $253K.
- Raymond James & Associates first reported a position in Annexon in Q3 2021 and held it in 2 quarters.
- Raymond James & Associates's Annexon position peaked at $410K in Q3 2021.
- 101 funds tracked by Wall St. Rank held Annexon as of Q1 2022.
Based on Raymond James & Associates's 13F filing for Q1 2022, filed 11 May 2022.